Nama Insights

Liquidia Corporation (LQDA)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

Liquidia Corporation (LQDA) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $8.02B, a trailing price-to-earnings ratio of 644.4 and a free-cash-flow yield of -0.5%. Over the most recent reported fiscal year, revenue grew 1031.2%.
Market cap$8.02B
Trailing P/E644.4
FCF yield-0.5%
Revenue growth (YoY)+1031.2%
EPS growth (YoY)
FCF/share growth (YoY)
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers Specialty Generic
Explore live LQDA data on Nama Insights →